Experience

Emergent BioSolutions

• United States
• Biotechnology Research
• 700 & Above Employee

• Vice President and General Manager, Canada

  • Jul 2016 - Present

  Emergent BioSolutions (NYSE: EBS) is a global life sciences company seeking to protect and enhance life by focusing on providing specialty products for civilian and military populations that address accidental, deliberate, and naturally occurring public health threats (www.emergentbiosolutions.com). ● Leading all aspects of Canadian business for NARCAN®: an FDA and Health Canada-approved naloxone nasal spray and opioid antagonist used to reverse known or suspected opioid overdose (narcannasalspray.ca); ● Overseeing all aspects of strategic planning, corporate development, daily operations, sales, business development, marketing, performance, communications, channel management, customer service, partnering, compliance and HR with full P&L responsibility; ● Establishing strategic agenda, direction, business infrastructure and best practice programs and processes; ● Managing a team of direct reports and external consultants; ● Driving advocacy and sales to consumers through retail pharmacies, distributors and group purchasers including first responders, Government Health departments and community-based organizations. ● Prior to acquisition by Emergent in 2018, launched Adapt Pharma Canada Ltd. in 2016 and profitably built a multimillion-dollar business including planning/leading the launch of the business and brand in Canada, establishing market access and footprint, developing every facet of the organization and its operations and partnerships, identifying and working with non-traditional and traditional customers, and managing the entire seamless transition from US-labelled NARCAN® to Canadian-labelled NARCAN®.



PharmaChat

• Pharmaceutical Manufacturing
• 1 - 100 Employee

• Managing Director

  • Jan 2015 - Dec 2016

  PharmaChat is a Digital and Social Media Intelligence company that delivers actionable, strategic, data-driven, patient-centric research and insights to Canada’s pharmaceutical and biotech industries by leveraging advanced social media search technology coupled with proprietary methods and practices (www.pharmachat.ca). ● Led strategic consulting, business planning and development of a national sales strategy; ● Co-developed branding, products and associated value propositions targeting pharmaceutical industry customers.



BrandBuild Healthcare Inc.

• Mississauga, Ontario, Canada Area

• President & Founder

  • Oct 2006 - Jul 2016

  BrandBuild was a consulting firm empowering pharma and medical device companies with marketing and business development, management, implementation and measurement solutions as well as the commercialization and branding of healthcare products and services in Canada and the US (www.brandbuild.ca) ● Planned, led and supported sales, marketing, product/channel development, partnering and service operations for healthcare clients; ● Evaluated market opportunities, costing and commercial/regulatory barriers to help foreign companies to navigate entry into the Canadian marketplace. ACHIEVEMENTS: ► (Iroko Pharamceuticals): Launched a US virtual pharma company with no physical presence in Canada, led 2 product entries, oversaw all operations and delivered 22% increase in top line sales ($1.2M+) of a mature, non-promoted brand in 18 months. ► (Manna X Corporation 2012/13): Served as GM for the manufacturer of Advantage+ dietary supplements and built Canadian distribution and market. ►(Concordia Healthcare, 2013/14): Oversaw US commercial functions including launches, sales, business development, market/channel development, marketing, pricing, transition and Canadian market planning for 3 acquired legacy products with peak sales of $100M+. ► (The Pangaea Group): Led a consulting firm assisting US and Canadian healthcare executives and managed 25 clients including Roche, Allergan, Astellas, Purdue, Novo Nordisk, Bayer, Merus Labs, Alexion, Amgen, Nycomed and Takeda. ► KRIM Biopharma (1-year contract): From start up, acted as EVP Commercial and led financial/commercial analyses, due diligence, preparation of term sheets and offers to acquire legacy pharmaceutical brands in the US and Canada; established US state licenses and operations; oversaw the transition/integration of key regulatory, manufacturing, pricing and commercial functions; ensured commercial compliance and reporting; developed corporate and brand plans; supported private/institutional investment.



Oryx Pharmaceuticals

• Mississauga, Ontario, Canada Area

• Director of Sales and Marketing

  • Jul 2002 - Oct 2006

  Acquired by Sunovion in 2008 for $50M+, Oryx was a specialty Canadian pharmaceutical company that commercialized prescription and hospital products through purchasing, licensing and development with a focus in the cardiovascular, central nervous system (CNS) disorders, pain and infectious disease therapeutic areas. ● Reported to the President, co-developed the company's organizational structure from start-up and directed all aspects of national business development, sales and marketing; ● Managed a team of 5 field sales agents, 3 brand managers, an administrator and annual budgets up to $2.4M; ● Directed pricing, packaging, market access, distribution, advertising, promotions, licensing, reimportation and vendor network; ● Developed relationships with US partners and industry agencies and delivered key presentations to senior executives, provincial governments, and partners. ACHIEVEMENTS: ► From start-up, co-developed the company's organizational structure ► Exceeded all performance targets in each year ► Grew the product portfolio from 2 to 10+ products ► Planned and directed the launch of two products that generated approximately $10M in sales in 2006 ► Instrumental in realizing overall company growth of 100% in 2005 and 50% in 2006 while managing budgets to within 5% of prescribed amount year-after-year



AstraZeneca

• United Kingdom
• Pharmaceutical Manufacturing
• 700 & Above Employee

• Senior Product Manager

  • Apr 2001 - Jul 2002

  With 600 employees and products used by over three million Canadians, AstraZeneca Canada is a division of a global biopharmaceutical working in 100+ countries and generating sales of $28B in 2012 (www.astrazeneca.ca).● Promoted to develop brand strategy and lead the highly successful Canadian launch of megabrand Symbicort: a revolutionary asthma medication that had projected sales of $100M+ and $1B worldwide within 24 months of launch;● Managed 4 direct reports, led a multidisciplinary 14-person launch team and oversaw hiring and development of the marketing team;● Administered $14M in advertising and promotional spending and negotiated and managed outside supplier contracts from $500K to $1.5M;● Developed training programs, sales workshops and KOL development initiatives, including clinical training, peer-to-peer functions, lunch-and-learn programs and a $1M, 100-person scientific advisory meeting in Arizona.; ● Represented Canadian operations on the AstraZeneca’s Megabrand Best Practices Committee and the International Marketing Committee.ACHIEVEMENTS: ► Instrumental in planning and realizing the company's most successful product uptake in category history ► Achieved 80% awareness and 90% intent to prescribe across all specialties in 3 months ► Captured 30% NRx share within 8 weeks of launch ► Outpaced the growth of the market leader after only 4 months

• Product Manager

  • Feb 1998 - Apr 2001

  (See above company overview)● Contributed to the development of the company’s branding platform including core marketing strategies, product positioning, pricing, market research, public affairs, publications, medical education, opinion leader development, and marketing campaigns for products at various stages in the brand life-cycle;● Actively supported sales and approved and coordinated the development and rollout of print campaigns; ● Hired/trained staff and leveraged an extensive network of physician opinion leaders.ACHIEVEMENTS: ► Directed a switch campaign that delivered an incremental $1M in investment and a 5% market share gain for Pulmicort, a corticosteroid that treats asthma ► Managed post-launch initiatives to secure $3.5M in sales of Accolate, the first oral leukotriene receptor antagonist (LTRA) in Canada for the maintenance treatment of asthma



Procter & Gamble

• United States
• Manufacturing
• 700 & Above Employee

• Associate Product Manager

  • Nov 1996 - Feb 1998

  With approximately 800 employees in Canada, P&G Pharmaceuticals Canada is a division of P&G's global pharmaceutical organization that was acquired by Warner Chilcott in 2009 for a cash payment of $3.1B. ● Oversaw daily brand operations, sales support, and life-cycle management on the regional and national levels for Asacol (used in ulcerative colitis to treat inflammation in the large intestine); ● Worked closely with KOLs to promote product adoption, developed journal advertising and delivered key presentations to internal management and the North American brand management team. ACHIEVEMENTS: ► Preserved annual business of $500K by developing and co-leading a successful brand defense from a patent challenge and a competitor's generic product launch ► Excelled in an industry-leading training program for highly-specialized consumer goods brand management



Pfizer

• United States
• Pharmaceutical Manufacturing
• 700 & Above Employee

• Medical Sales Representative

  • Jun 1995 - Jul 1996

  Pfizer Canada Inc. is the Canadian operation of Pfizer Inc., one of the world’s leading biopharmaceutical companies (www.pfizer.ca). ● Sold products to physicians and hospitals in a $1M downtown Toronto territory during a period of significant company growth and reorganization; ACHIEVEMENTS: ► Achieved 50% growth in one year for two products in an underdeveloped territory. Pfizer Canada Inc. is the Canadian operation of Pfizer Inc., one of the world’s leading biopharmaceutical companies (www.pfizer.ca). ● Sold products to physicians and hospitals in a $1M downtown Toronto territory during a period of significant company growth and reorganization; ACHIEVEMENTS: ► Achieved 50% growth in one year for two products in an underdeveloped territory.



Zeneca Pharmaceuticals

• Pharmaceutical Manufacturing
• 1 - 100 Employee

• Senior Medical Sales Representative

  • Dec 1993 - Jun 1995

  Zeneca Pharma Canada was the Canadian division of a leading pharmaceutical company and manufacturer of anti-cancer and hypertension products. ● Drove sales and account service in London Ontario. ACHIEVEMENTS: ► Earned the General Manager’s Award for Sales Excellence twice (top 6 in national sales force) ► Representative of the Year in 1994 (after only one year in the industry); ► Achieved the highest rate of sales growth in the country out of 40 sales representatives ► Consistently exceeded quarterly sales revenue targets ► Increased sales force effectiveness by spearheading and leading the evaluation, implementation and companywide rollout of a new territory management system ► Appointed as the District Sales Trainer for Manitoba and Western Ontario



Zeneca Pharma Canada Inc.

• Mississauga, Ontario, Canada Area

• Medical Representative

  • Apr 1992 - Dec 1993



RBC

• Canada
• Banking
• 700 & Above Employee

• Manager of Customer Service

  • Sep 1990 - Sep 1991